Verdence Capital Advisors’s Omnicell OMCL Stock Holding History

Verdence Capital Advisors’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,306	Closed	-$201K	–	536
2022 Q3	$201K	Buy	2,306 +73	+3%	+$7.67K	0.03%	490
2022 Q2	$254K	Buy	+2,233	New	+$256K	0.03%	433
2022 Q1	–	Sell	-1,231	Closed	-$222K	–	529
2021 Q4	$222K	Buy	+1,231	New	+$214K	0.03%	467

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Verdence Capital Advisors's OMCL Position: Q4 2022 in Review

Verdence Capital Advisors sold out of Omnicell (OMCL) in Q4 2022, closing a stake of 2,306 shares — an estimated $201K sold.

Verdence Capital Advisors first reported a position in OMCL in Q4 2021 and held it in 3 quarters. The position peaked at $254K in Q2 2022. 329 funds tracked by Wall St. Rank hold OMCL as of Q4 2022.

Verdence Capital Advisors reported no remaining Omnicell position as of Q4 2022 after selling out during the quarter.
Verdence Capital Advisors sold 2,306 Omnicell shares in Q4 2022, an estimated $201K.
Verdence Capital Advisors first reported a position in Omnicell in Q4 2021 and held it in 3 quarters.
Verdence Capital Advisors's Omnicell position peaked at $254K in Q2 2022.
329 funds tracked by Wall St. Rank held Omnicell as of Q4 2022.

Based on Verdence Capital Advisors's 13F filing for Q4 2022, filed 23 Jan 2023.